NewTimeSpace News:On March 12, 2026, Trendlines announced that IBI Ag, a portfolio company it incubated and invested in, has successfully completed the Proof of Concept for its AI-powered de novo protein design platform for novel bioinsecticides. This breakthrough marks a major step forward in the development of eco-friendly pest control solutions and demonstrates the technological innovation strength of Trendlines' portfolio companies.

According to the announcement, the POC included the design of novel proteins and their validation through insect bioassays, with the designed proteins proven effective in controlling key agricultural pests. By integrating cutting-edge AI technology with proprietary biological data, IBI Ag has developed an innovative computational design approach that can precisely target pests while minimizing impacts on beneficial insects and the environment, breaking the R&D bottleneck of traditional bioinsecticides that rely on naturally occurring proteins.

Arnon Heyman, CEO of IBI Ag, stated that this is the world’s first de novo protein design platform for bioinsecticides. Leveraging the company’s proprietary intellectual property, the platform enables the discovery and validation of novel proteins based on massive volumes of data, representing a transformative breakthrough for the industry. It not only upholds the concept of sustainable development but also helps farmers boost crop yields while protecting ecological systems.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.